News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Biotech Beach
Somanta Pharmaceuticals, Inc. To Present At Merriman Curhan Ford ''Investor Summit 2006'’ On September 18
September 15, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON & IRVINE, Calif.--(BUSINESS WIRE)--Sept. 15, 2006--Somanta Pharmaceuticals (OTCBB:SMPM) today announced it will present at the Merriman Curhan Ford "Investor Summit 2006" to be held September 18-20 at the Mark Hopkins Hotel in San Francisco.
Twitter
LinkedIn
Facebook
Email
Print
Events
Europe
MORE ON THIS TOPIC
Company closure
6 biotechs that called it quits in Q1
April 30, 2026
·
6 min read
·
Angela Gabriel
gene editing
Gene therapy leaders aim to help more Baby KJs with novel regulatory models
April 27, 2026
·
5 min read
·
Heather McKenzie
Regulatory
Amid US ordeal, Moderna wins EU approval for flu/COVID-19 combo shot
April 22, 2026
·
2 min read
·
Tristan Manalac
Cancer
Merck’s PD-1/VEGF data star in stacked lineup of AACR ‘26 data reveals
April 17, 2026
·
5 min read
·
Nick Paul Taylor